1,349
Views
8
CrossRef citations to date
0
Altmetric
Original Research

Blood concentrations of proapoptotic sFas and antiapoptotic Bcl2 and COVID-19 patient mortality

, , , , , , , , , & show all
Pages 837-844 | Received 13 Jan 2021, Accepted 08 Jun 2021, Published online: 27 Jun 2021

References

  • World Meters. Coronavirus disease (COVID-19). Assessed January 7, 2021 https://www.worldometers.info/coronavirus/coronavirus-cases
  • Ruan Q, Yang K, Wang W, et al. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020 Mar 3. Epub ahead of print. DOI:10.1007/s00134-020-05991-x
  • Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054–1062. .
  • Lorente L, Martín MM, Franco A, et al. Working Group on COVID-19 Canary ICU; Annex. Members of the BIOMEPOC group. HLA genetic polymorphisms and prognosis of patients with COVID-19. Med Intensiva. 2020 Sep 6. S0210-5691(20)30266-7. doi: 10.1016/j.medin.2020.08.004. Epub ahead of print. .
  • Wu C, Chen X, Cai Y, et al. risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 pneumonia in Wuhan, China. JAMA Intern Med. 2020 Mar 13;180(7):934. Epub ahead of print.
  • Henry BM, de Oliveira MHS, Benoit S, et al. Hematologic, biochemical and immune biomarker abnormalities associated with severe illness and mortality in coronavirus disease 2019 (COVID-19): a meta-analysis. Clin Chem Lab Med. 2020;58(7):1021–10281021–1028. Apr 10 [Epub ahead of print]. .
  • Lorente L, Martín MM, Argueso M, et al. Association between red blood cell distribution width and mortality of COVID-19 patients. Anaesth Crit Care Pain Med. 2021 Nov 7;40(1): 100777. doi: 10.1016/j.accpm.2020.10.013. Epub ahead of print. . DOI:
  • Du RH, Liang LR, Yang CQ, et al. Predictors of mortality for patients with COVID-19 pneumonia caused by SARS-CoV-2: a prospective cohort study. Eur Respir J. 2020;55. DOI:10.1183/13993003.00524-2020.
  • Lorente L, Gómez-Bernal F, Martín MM, et al. Working Group on COVID-19 Canary ICU. High serum nitrates levels in non-survivor COVID-19 patients. Med Intensiva. 2020 Nov 10. S0210-5691(20)30336-3. doi: 10.1016/j.medin.2020.10.003. Epub ahead of print. PMID: 33293102.
  • Harjai M, Bogra J, Kohli M, et al. Is suppression of apoptosis a new therapeutic target in sepsis? Anaesthesia and Intensive Care. 2013;41(2):175–183.
  • Cizmecioglu A, Akay Cizmecioglu H, Goktepe MH, et al. T-cell lymphopenia is related to COVID-19 severity. J Med Virol. 2021;93:2867–2874.
  • Taghiloo S, Aliyali M, Abedi S, et al. Apoptosis and immunophenotyping of peripheral blood lymphocytes in Iranian COVID-19 patients: clinical and laboratory characteristics. J Med Virol. 2021;93(3):1589–1598.
  • Bellesi S, Metafuni E, Hohaus S, et al. V. Increased CD95 (Fas) and PD-1 expression in peripheral blood T lymphocytes in COVID-19 patients [published online ahead of print. Br J Haematol. 2020 Jul 17;191(2):207–211. 2020.
  • Zhu L, Yang P, Zhao Y, et al. Single-cell sequencing of peripheral mononuclear cells reveals distinct immune response landscapes of COVID-19 and influenza patients [published online ahead of print. Immunity. 2020 Jul 19 2020;S1074-7613(20)30316-2. 10.1016/j.immuni.2020.07.009.
  • Haljasmägi L, Salumets A, Rumm AP, et al. Longitudinal proteomic profiling reveals increased early inflammation and sustained apoptosis proteins in severe COVID-19. Sci Rep. 2020;10(1):20533.
  • Iwalokun BA, Olalekan A, Adenipekun E, et al. Improving the understanding of the immunopathogenesis of lymphopenia as a correlate of SARS-CoV-2 infection risk and disease progression in African patients: protocol for a cross-sectional study. JMIR Res Protoc. 2021;10(3):e21242.
  • Henry BM, Cheruiyot I, Benoit SW, et al. Cytokeratin 18 cell death assays as biomarkers for quantification of apoptosis and necrosis in COVID-19: a prospective, observational study. J Clin Pathol. 2021 Mar 31; jclinpath-2020-207242. Epub ahead of print. DOI:10.1136/jclinpath-2020-207242
  • Lorente L, Martín MM, Ortiz-López R, et al. Association of serum soluble Fas concentrations and mortality of septic patients. Enferm Infecc Microbiol Clin. 2020 2020 Sep 21;S0213-005X(20)30268-8. doi: 10.1016/j.eimc.2020.08.003. Online ahead of print.
  • Lorente L, Martín MM, Ortiz-López R, et al. Circulating Bcl-2 concentrations and septic patient mortality [published online ahead of print. Enferm Infecc Microbiol Clin. 2020 Jul 14 2020;S0213-005X(20)30232-9. 10.1016/j.eimc.2020.06.001.
  • VM R, Gd R, Bt T, et al., ARDS Definition Task Force. Acute respiratory distress syndrome: the Berlin Definition. JAMA. 2012;307(23):2526–2533.
  • Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985;13(10):818–829.
  • Vincent JL, Moreno R, Takala J, et al. The SOFA (Sepsis-related Organ Failure Assessment) score to describe organ dysfunction/failure. Intensive Care Medicine. 1996;22(7):707–710. .
  • Chung C-S, Song GY, Lomas J, et al. Inhibition of Fas/Fas ligand signaling improves septic survival: differential effects on macrophage apoptotic and functional capacity. J Leukoc Biol. 2003;74(3):344–351.
  • Wesche-Soldato DE, Chung C-S, Lomas-Neira J, et al. In vivo delivery of caspase-8 or Fas siRNA improves the survival of septic mice. Blood. 2005;106(7):2295–2301.
  • Matsuda N, Yamamoto S, Takano K, et al. Silencing of fas-associated death domain protects mice from septic lung inflammation and apoptosis. Am J Respir Crit Care Med. 2009;179(9):806–815. .
  • Matsuda N, Teramae H, Yamamoto S, et al. Increased death receptor pathway of apoptotic signaling in septic mouse aorta: effect of systemic delivery of FADD siRNA. Am J Physiol Heart Circ Physiol. 2010;298(1):H92–H101.
  • Zhou M, Simms HH, Wang P. Adrenomedullin and adrenomedullin binding protein-1 attenuate vascular endothelial cell apoptosis in sepsis. Ann Surg. 2004;240(2):321–330.
  • Hariyanto TI, Japar KV, Kwenandar F, et al. Inflammatory and hematologic markers as predictors of severe outcomes in COVID-19 infection: a systematic review and meta-analysis. Am J Emerg Med. 2021;41:110–119.
  • Ivan Hariyanto T, Kurniawan A. Tocilizumab administration is associated with the reduction in biomarkers of coronavirus disease 2019 infection. J Med Virol. 2021;93(3):1832–1836.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.